Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications

References

• Verma R, Balhara YP, Mathur S. Management of attention-deficit hyperactivity disorder. J Pediatr Neurosci 2011;6:13-18
   PubMedGoogle Scholar
• Danckaerts M, Sonuga-Barke EJ, Banaschewski T, et al. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry 2010;19:83-105
   PubMed Web of Science ®Google Scholar
• Geissler J, Lesch KP. A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms. Expert Rev Neurother 2011;11:1467-84
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder – Diagnosis and management of ADHD in children, young people and adults – NICE clinical guideline 72. 2009. Available at: http://www.nice.org.uk/nicemedia/live/12061/42059/42059.pdf
   Google Scholar
• MTA Cooperative Group. Multimodal treatment study of children with ADHD. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-86
   PubMed Web of Science ®Google Scholar
• Spencer, TJ. ADHD treatment across the life cycle. J Clin Psychiatry 2004;65:22-6
   PubMed Web of Science ®Google Scholar
• Group Health. Attention Deficit Hyperactivity Disorder (ADHD): Adults – Diagnosis and Treatment Guideline. 2011. Available at: https://www.ghc.org/all-sites/guidelines/adhd-adult.pdf
   Google Scholar
• Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in ADHD: effects of treatment and non-treatment. BMC Med 2012;10:99
   PubMed Web of Science ®Google Scholar
• Cascade E, Kalali AH, Weisler RH, et al. Seasonality and the changing adult/child prescription ratios in ADHD Therapy. Psychiatry (Edgmont) 2008;5:23-5
   PubMedGoogle Scholar
• Canadian ADHD Practice Guidelines (CAP Guidelines). 3rd edn. 2010. Available at: http://www.caddra.ca/cms4/pdfs/caddraGuidelines2011.pdf
   Google Scholar
• Murray-Close D, Hoza B, Hinshaw S, et al. Developmental processes in peer problems of children with ADHD in the MTA Study: developmental cascades and vicious cycles. Dev Psychopathol 2010;22:785-802
   PubMed Web of Science ®Google Scholar
• McCarthy S, Asherson P, Coghill D, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 2009;194:273-7
   PubMed Web of Science ®Google Scholar
• Sobanski E, Sabljic D, Alm B, et al. Driving performance in adults with ADHD: results from a randomized, waiting list controlled trial with atomoxetine. Eur Psychiatry 2013;28:379-85.
   PubMed Web of Science ®Google Scholar
• Jerome L, Segal A, Habinski L. What we know about ADHD and driving risk: a literature review, meta-analysis and critique. J Can Acad Child Adolesc Psychiatry 2006;15:105-25
   PubMed Web of Science ®Google Scholar
• Barner J, Khoza S, Oladapo A. ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Curr Med Res Opin 2011;27(2 Suppl):13-22
   PubMed Web of Science ®Google Scholar
• Christensen L, Sasané R, Hodgkins P, et al. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 2010;26:977-89
   PubMed Web of Science ®Google Scholar
• Wong IC, Asherson P, Bilbow A, et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)—a pharmacoepidemiological and qualitative study. Health Technol Assess 2009;13:iii-iv, ix–xi, 1–120
   PubMed Web of Science ®Google Scholar
• Perring C. Medicating children: the case of ritalin. Bioethics 1997;11:228-40
   PubMed Web of Science ®Google Scholar
• Brinkman W, Epstein J. Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences. Patient Prefer Adherence 2011;5:45-56
   Web of Science ®Google Scholar
• Van den Ban E, Souverein PC, Hanna Swaab H, et al. Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands. ADHD Atten Def Hyp Disord 2010;2:213-20
   PubMedGoogle Scholar
• van de Loo-Neus G, Rommelse N, Buitelaar J. To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol 2011;21:584-99
   PubMed Web of Science ®Google Scholar
• Kaplan G, Newcorn J. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder. Pediatr Clin N Am 2011;58:99-120
   PubMed Web of Science ®Google Scholar
• Setyawan J, Hodgkins P, Guerin A, et al. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis: a retrospective analysis J Med Econ 2013;16:962--75
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Kruzikas D. Comorbidity software documentation. HCUP Methods Series Report # 2004-1. ONLINE February 6, 2004. US Agency for Healthcare Research and Quality; 2004. http://www.hcupus.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp. [Accessed 12 Sep 2013]
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition [DSM-IV]. APA; 1994. Washington, doi:10.1176/appi.books.9780890423349.7060
   Google Scholar
• Marcus SC, Wan GJ, Kemner JE, et al. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2005;159:572-8
   PubMed Web of Science ®Google Scholar
• Winterstein AG, Gerhard T, Shuster J, et al. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother 2008;42:24-31
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services; Medicaid by Population. Medicaid website. http://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Population/By-Population.html. Accessed March 2013
   Google Scholar
• Bones RK, Pérez K, Rodríguez-Sanz M, et al. Prevalence of mental health problems and their association with socioeconomic, work and health variables: findings from the Spain National Health Survey. Psicothema 2010;22:389-95
   PubMed Web of Science ®Google Scholar
• Davis E, Sawyer MG, Lo SK, et al. Socioeconomic risk factors for mental health problems in 4-5-year-old children: Australian population study. Acad Pediatr 2010;10:41-7
   PubMed Web of Science ®Google Scholar
• Hudson CG. Socioeconomic status and mental illness: tests of the social causation and selection hypotheses. Am J Orthopsychiatry 2005;75:3-18
   PubMed Web of Science ®Google Scholar
• Ibrahim AK, Kelly SJ, Glazebrook C. Socioeconomic status and the risk of depression among UK higher education students. Soc Psychiatry Psychiatr Epidemiol 2013;48:1491-501
   Google Scholar